Shared on 01 Nov 25
Fair value Increased 3.00%Analysts have increased their price target for McEwen, raising it from $23.30 to $24.00 per share. They cite the updated feasibility study for the Los Azules project and continued robust support from both government and industry stakeholders as key drivers of this upward revision.
Shared on 18 Oct 25
Fair value Increased 42%Analysts have raised their price target for McEwen from $16.44 to $23.30 per share. They cite the recent positive feasibility study on the Los Azules project and significantly improved financial forecasts as key reasons for this change.
Shared on 03 Oct 25
Fair value Increased 7.35%Analysts have raised their price target for McEwen, increasing it by $1.13 to $16.44. They cited updated financial outlooks and sustained confidence in the company's performance.
Shared on 23 Apr 25
Fair value Decreased 8.85%AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.
Shared on 09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 3.30%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 0.82%AnalystConsensusTarget has decreased revenue growth from 11.5% to 2.2%, increased profit margin from 4.3% to 8.6% and decreased future PE multiple from 116.4x to 74.5x.
Shared on 19 Mar 25
Fair value Increased 2.50%AnalystConsensusTarget made no meaningful changes to valuation assumptions.